Trials / Recruiting
RecruitingNCT06065306
Potential Diagnostic Biomarkers for Aortic Dissection in the Emergency Department
Potential Diagnostic Biomarkers for Aortic Dissection in the Emergency Department: the Aggrecan, Desmosine, D-dimer-Emergency Department (ADD-ED) Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 47 (estimated)
- Sponsor
- Chinese University of Hong Kong · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this observational study is to determine the utility of desmosine, D-dimer and aggrecan as early diagnostic biomarkers in aortic dissection. The main questions it aims to answer are: * To investigate the plasma levels of selected biomarkers in ED patients with confirmed aortic dissection * To study the diagnostic performance of plasma levels of selected biomarkers for aortic dissection * To study the association between plasma levels of selected biomarkers and clinical outcomes
Conditions
Timeline
- Start date
- 2023-06-18
- Primary completion
- 2024-12-31
- Completion
- 2025-12-31
- First posted
- 2023-10-03
- Last updated
- 2024-04-16
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT06065306. Inclusion in this directory is not an endorsement.